Total properties:
10
|
|
Patent #:
|
|
Issue Dt:
|
09/08/2020
|
Application #:
|
15569726
|
Filing Dt:
|
10/26/2017
|
Publication #:
|
|
Pub Dt:
|
05/10/2018
| | | | |
Title:
|
MORPHINAN DERIVATIVES FOR THE TREATMENT OF NEUROPATHIC PAIN
|
|
|
Patent #:
|
|
Issue Dt:
|
09/10/2019
|
Application #:
|
15719376
|
Filing Dt:
|
09/28/2017
|
Publication #:
|
|
Pub Dt:
|
01/18/2018
| | | | |
Title:
|
KAPPA OPIOID AGONISTS AND USES THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
11/05/2019
|
Application #:
|
15723943
|
Filing Dt:
|
10/03/2017
|
Publication #:
|
|
Pub Dt:
|
01/25/2018
| | | | |
Title:
|
MULTI-ARM POLYMER PRODRUGS
|
|
|
Patent #:
|
|
Issue Dt:
|
01/07/2020
|
Application #:
|
15723981
|
Filing Dt:
|
10/03/2017
|
Publication #:
|
|
Pub Dt:
|
02/01/2018
| | | | |
Title:
|
COMPOSITIONS AND METHODS FOR ACHIEVING SUSTAINED THERAPEUTIC DRUG CONCENTRATIONS IN A SUBJECT
|
|
|
Patent #:
|
|
Issue Dt:
|
10/11/2022
|
Application #:
|
15788626
|
Filing Dt:
|
10/19/2017
|
Publication #:
|
|
Pub Dt:
|
09/13/2018
| | | | |
Title:
|
OLIGOMER-CORTICOSTEROID CONJUGATES
|
|
|
Patent #:
|
|
Issue Dt:
|
12/04/2018
|
Application #:
|
15791951
|
Filing Dt:
|
10/24/2017
|
Publication #:
|
|
Pub Dt:
|
09/13/2018
| | | | |
Title:
|
OLIGOMER-OPIOID AGONIST CONJUGATES
|
|
|
Patent #:
|
|
Issue Dt:
|
06/16/2020
|
Application #:
|
15792060
|
Filing Dt:
|
10/24/2017
|
Publication #:
|
|
Pub Dt:
|
02/15/2018
| | | | |
Title:
|
POLYMER-SUNITINIB CONJUGATES
|
|
|
Patent #:
|
|
Issue Dt:
|
08/20/2019
|
Application #:
|
15799754
|
Filing Dt:
|
10/31/2017
|
Publication #:
|
|
Pub Dt:
|
02/22/2018
| | | | |
Title:
|
N-MALEIMIDYL POLYMER DERIVATIVES
|
|
|
Patent #:
|
|
Issue Dt:
|
10/29/2019
|
Application #:
|
15807335
|
Filing Dt:
|
11/08/2017
|
Publication #:
|
|
Pub Dt:
|
03/08/2018
| | | | |
Title:
|
METHOD INVOLVING 1-BENZOTRIAZOLYL CARBONATE ESTERS OF POLY(ETHYLENE GLYCOL)
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
15835072
|
Filing Dt:
|
12/07/2017
|
Publication #:
|
|
Pub Dt:
|
04/05/2018
| | | | |
Title:
|
METHOD FOR PREDICTING AND EVALUATING RESPONSIVENESS TO CANCER TREATMENT WITH DNA-DAMAGING CHEMOTHERAPEUTIC AGENTS
|
|